RSV vaccine use – the missing data

Simon Drysdale; Charles Sande; Christopher Green; Andrew Pollard

RSV vaccine use – the missing data

Simon Drysdale, Charles Sande, Christopher Green, Andrew Pollard

Research output: Contribution to journal › Review article › peer-review

11 Citations (Scopus)

Abstract

Respiratory syncytial virus (RSV) infection is the most important cause of hospitalization in infants and is one of the leading global causes of infant mortality and as such its prevention through vaccination is a public health priority. While essential for the successful implementation of vaccine programs, there remains a paucity of data on the epidemiology of the virus in different settings and age groups and limited knowledge about virus transmission and the health-care costs of the disease. Such data are now needed to populate health economic models and to inform optimal approaches to disease control through vaccination.

Original language	English
Journal	Expert Review of Vaccines
Publication status	Published - 2016
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{b5c8552f7d4e42b6925c084d1123eb0a,

title = "RSV vaccine use – the missing data",

abstract = "Respiratory syncytial virus (RSV) infection is the most important cause of hospitalization in infants and is one of the leading global causes of infant mortality and as such its prevention through vaccination is a public health priority. While essential for the successful implementation of vaccine programs, there remains a paucity of data on the epidemiology of the virus in different settings and age groups and limited knowledge about virus transmission and the health-care costs of the disease. Such data are now needed to populate health economic models and to inform optimal approaches to disease control through vaccination.",

author = "Simon Drysdale and Charles Sande and Christopher Green and Andrew Pollard",

year = "2016",

language = "English",

journal = "Expert Review of Vaccines",

issn = "1476-0584",

publisher = "Informa Healthcare",

}

TY - JOUR

T1 - RSV vaccine use – the missing data

AU - Drysdale, Simon

AU - Sande, Charles

AU - Green, Christopher

AU - Pollard, Andrew

PY - 2016

Y1 - 2016

N2 - Respiratory syncytial virus (RSV) infection is the most important cause of hospitalization in infants and is one of the leading global causes of infant mortality and as such its prevention through vaccination is a public health priority. While essential for the successful implementation of vaccine programs, there remains a paucity of data on the epidemiology of the virus in different settings and age groups and limited knowledge about virus transmission and the health-care costs of the disease. Such data are now needed to populate health economic models and to inform optimal approaches to disease control through vaccination.

AB - Respiratory syncytial virus (RSV) infection is the most important cause of hospitalization in infants and is one of the leading global causes of infant mortality and as such its prevention through vaccination is a public health priority. While essential for the successful implementation of vaccine programs, there remains a paucity of data on the epidemiology of the virus in different settings and age groups and limited knowledge about virus transmission and the health-care costs of the disease. Such data are now needed to populate health economic models and to inform optimal approaches to disease control through vaccination.

M3 - Review article

SN - 1476-0584

JO - Expert Review of Vaccines

JF - Expert Review of Vaccines

ER -

RSV vaccine use – the missing data

Abstract

UN SDGs

Fingerprint

Cite this